Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Organovo Announces Commercial Release of the exVive3D™ Human Liver Tissue
Friday, November 21, 2014
exVive3D™ human liver tissue for preclinical drug discovery testing.

New Whitepaper from Malvern Instruments
Friday, November 21, 2014
Explores how Malvern extends a QbD approach to instrument design.

AB SCIEX Expands Software Capability To Include DiscoveryQuantTM 3.0 Software
Thursday, November 06, 2014
DiscoveryQuant 3.0 Software increases efficiency for data analysis in high throughput drug discovery laboratory for all molecule types.

Randox Launches World’s Most Comprehensive Third Party Haematology Control
Wednesday, October 29, 2014
Randox Laboratories has launched a third party multi-analyte haematology control; the most comprehensive haematology quality control (QC) solution on the market to date.

Malvern Exhibits Recently Acquired MicroCal and NanoSight Brands at AAPS 2014
Tuesday, October 28, 2014
Company showcases rapidly growing portfolio of analytical solutions for pharma and biopharma applications.

Tecan’s AC Extraction Plate™ Boosts Productivity for Clozapine Testing
Saturday, October 25, 2014
King’s College Hospital has established a fully automated therapeutic drug monitoring protocol for clozapine.

New Accessories for the Mastersizer 3000 from Malvern Instruments
Friday, October 17, 2014
New accessories support smarter pharmaceutical particle size analysis.

New Additions to Malvern Instruments’ ‘10 ways to…’ Whitepaper Series
Saturday, October 11, 2014
Two new additions to whitepaper series guide rheological optimization of dispersion products.

High Throughput Biological Sample Concentrator
Tuesday, September 16, 2014
The miVac Quattro from Genevac is the perfect workhorse sample concentrator for biological laboratories tasked with handling larger numbers of samples.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 655
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv